Arthur R. Thompson

Hematology
325 9th Ave Fl 16
Seattle, WA 98104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications

Hypoxia Modulates Platelet Purinergic Signalling Pathways.

Hypoxia Modulates Platelet Purinergic Signalling Pathways.

Journal: Thrombosis and haemostasis
Published: December 21, 2019

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.

Journal: Blood advances
Published: December 23, 2017

T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.

T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.

Journal: Blood
Published: November 24, 2015

Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.

Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.

Journal: PloS one
Published: July 08, 2014

Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.

Factor VIII mutation and desmopressin-responsiveness in 62 patients with mild haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 08, 2013

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.

Journal: Blood
Published: January 28, 2012

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

Journal: Blood
Published: November 24, 2011
Showing 1-7 of 7

Last Updated: 09/26/2026